- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology Europe-12-01-2008
Pharmaceutical Technology Europe
20th Anniversary Special Feature: Validation and qualification
December 01, 2008
Regulatory Report
20
12
How has pharmaceutical manufacturing validation influenced analytical instrument qualification during the last 20 years and what are the emerging trends for the future?
The long awaited revision
December 01, 2008
Regulatory Report
20
12
The closing date for comments to be received by the US Pharmacopeia (USP) for proposed revisions to Chapter , which deals with analysis of heavy metals, is 15 December 2008. The USP has been working towards for approximately 4 years and the task has not been easy.
A novel aid for the preparation of pellets by extrusion/spheronization
December 01, 2008
Viewpoint
20
12
Microcrystalline cellulose is the main excipient used in the industrial manufacture of pellets by extrusion/spheronization, but pellets containing this spheronizing aid do not readily disintegrate and are expensive.
Better, wetter: an alternative approach to calcium carbonate granulation
December 01, 2008
Manufacturing & Processing
20
12
New research suggests calcium carbonate tablets are stronger and less porous when manufactured using a wet, rather than a dry, granulation process.
The dating agency
December 01, 2008
Spotlight
20
12
Hundreds of pharma–biotech deals have been announced during 2008 and many of these probably began at biopartnering conferences. Susan Aldridge examines some of this year's big buyouts and mergers.
VC: virtuous or vampire capital?
December 01, 2008
Biotech business
20
12
It is a universally acknowledged truth that a biotech start-up in possession of little fortune must be in want of venture capital (VC). Perhaps less well acknowledged, however, is that VC investors operate in a way consistent with being rational economic entities...
Assuring sterility with ASTM F 838-83
December 01, 2008
Manufacturing & Processing
20
12
Although realized in 1983, ASTM's standrad test method for determining bacterial retention of membrane filters used for liquid filtration is still hugely beneficial to today's pharmaceutical industry.
Partnership power
December 01, 2008
Business Talk
20
12
TranScrip Partners' Flic Gabbay explains why an approach that provides expertise on an 'as needed basis' is flourishing.
The Obama effect
December 01, 2008
Viewpoint
20
12
...the new administration is not anti-science or even anti-industry. It just wants lower prices.
Servier: patience and passion
December 01, 2008
Business
20
12
You don't have to spend any time in the company of its chairman to see that there is no other Big Pharma company like Servier.